A/G Ratio

This is one of the more useful numbers on a routine comprehensive metabolic panel that many people skip. It is calculated from albumin and total protein, so it often appears without a separate blood draw or a separate assay. It tracks a protein balance no single protein test captures on its own.

When it drifts low, one of three things is usually happening: you're making less albumin, losing albumin, or making more globulins because your immune system is active. In large human cohorts, lower serum A/G ratios predicted later cancer, kidney disease, and death at higher rates than higher ratios. Those are risk signals, not diagnoses.

What This Number Actually Compares

The A/G ratio divides albumin by globulin. Albumin is a single protein your liver makes at about 10 to 15 grams a day. It helps hold fluid inside blood vessels and carries hormones, vitamins, and many drugs. Globulins are a mixed group of proteins: antibodies, immune proteins, and carrier proteins. In plasma, clotting proteins can be part of that pool.

The useful part is that inflammation tends to push the two halves in opposite directions. Albumin is a negative acute-phase protein. That means it falls during inflammation. Some globulins rise with immune activation, especially antibodies in chronic disease. So the ratio can move more than either piece alone, which is why it may pick up a pattern albumin by itself would miss.

One caveat runs through everything below. The lab does not measure the ratio directly. It measures albumin and total protein, subtracts albumin to estimate globulin, then divides albumin by globulin. Anything that throws off albumin, total protein, or the albumin assay throws off the ratio. It is a screening signal, not a diagnosis.

Cancer Risk and Survival

The most direct preventive evidence comes from a study of 26,974 generally healthy Korean adults followed for a median of about six years. People with lower serum A/G ratios developed cancer and died at higher rates than those with higher ratios, and the link held after accounting for age, smoking, and other usual risk factors.

The pattern repeats in people who already have cancer. Pooling 28 studies covering 15,356 cancer patients, a low ratio before treatment came with about 75% higher risk of death. Similar results show up across colorectal, lung, and digestive cancers in separate pooled analyses. The studies did not use one shared cutoff, which matters: the direction of the signal is more reliable than any one lab line.

A low ratio is not a cancer diagnosis. Most people with a low ratio do not have cancer. It is a prompt to look for inflammation, low protein reserve, liver disease, kidney protein loss, or abnormal antibody production.

Death from All Causes

In 8,508 adults with diabetes followed for nearly a decade, people in the highest quarter of serum A/G ratio were about half as likely to die during follow-up as those in the lowest quarter. Heart-related and cancer deaths were lower too.

A separate Japanese study of 35,746 people did not use the A/G ratio directly. It measured albumin and gamma gap, the same ingredients viewed separately. Low albumin paired with low gamma gap carried the sharpest pneumonia-death signal, while low albumin paired with high gamma gap carried the sharpest signal for other respiratory deaths.

That pattern makes sense. A body with low protein reserve and a distorted immune-protein pattern is less well equipped to handle an acute infection.

Kidney Decline

A Korean community study followed 8,057 people who started without chronic kidney disease. Over follow-up, about one in five developed chronic kidney disease, and those in the lowest fifth of the serum A/G ratio were more likely to be among them. In people who already had kidney disease, lower ratios also tracked with higher death rates in stage 3 to 5 chronic kidney disease and in large dialysis cohorts.

Stroke, Heart Disease, and Autoimmune Activity

After acute ischemic stroke, people in the highest quarter of serum A/G ratio had lower death rates at both three months and one year. Better one-year recovery also tracked with a higher ratio. In lupus, a study of 101 patients found lower ratios in people with more active disease, and the ratio moved opposite the standard disease-activity score.

Across these settings, the ratio behaves less like a specific organ test and more like a running gauge of inflammatory stress and protein reserve.

Why a High Ratio Is Not Automatically Better

Higher isn't always better. If the ratio is high because globulins are unusually low, the question changes from inflammation to antibody production. That can happen with antibody deficiency, some genetic conditions, medication effects, or blood cancers. This is a balance gauge: a higher ratio is reassuring only when albumin and globulin both make sense.

When Results Can Be Misleading

Acute inflammation is the common trap. Infection, injury, and surgery can lower albumin, raise some immune proteins, and leave a result that looks worse than your baseline. The effect can linger after you feel better.

• Recent illness or surgery: major surgery and sepsis can lower albumin sharply by letting it leak out of blood vessels, while inflammatory proteins climb. This bends the ratio down even if your baseline is different.
• Hydration: dehydration concentrates the blood, while IV fluid dilutes it. Because the ratio uses two proteins, the effect is not always predictable, but either can shift the number without changing the underlying problem.
• Serum versus plasma and lab method: most outcome studies measured serum A/G. Some routine panels calculate it from serum or plasma, and albumin dye methods can disagree in kidney disease or when abnormal proteins are present. For trends, stay with the same lab when you can.
• Liver disease: your liver makes albumin, so advanced liver disease can lower the ratio for reasons that need a liver-focused workup, not just an inflammation workup.

Why One Reading Is Not Enough

Albumin is one of the steadier proteins in your blood. That stability is exactly what makes trending worthwhile: because the number does not bounce around much, a real downward drift over months carries signal.

In cancer patients, tracking the ratio over the year after surgery improved risk prediction beyond any single reading. That does not prove serial testing prevents cancer. It supports the simpler point: a trajectory tells you more than a dot.

What to Do With an Out-of-Pattern Result

A single low ratio is a prompt to investigate, not a verdict. First, rule out the obvious: were you recently sick, dehydrated, or drawn right after surgery? If so, repeat it a few weeks later when you are well.

If a low ratio persists, pair it with companion tests. hs-CRP is a blood inflammation marker. A liver panel helps show whether liver disease is lowering albumin. Creatinine and urine albumin-to-creatinine ratio help separate kidney filtration from kidney protein loss. If the globulin side is markedly high, serum protein electrophoresis is the follow-up. It separates the protein types and can flag multiple myeloma and related conditions, with a blood specialist involved if that pattern appears.